Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder.
NCT03885141
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
366
Enrollment
INDUSTRY
Sponsor class
Conditions
Insomnia Disorder
Interventions
DRUG:
Zolpidem
Sponsor
Biolab Sanus Farmaceutica